This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.
China Biologic Products, Inc. (CBPO) has risen 44.3% since the first of the year. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.
The price of Vipshop Holdings Ltd Sponsored ADR (VIPS) is up 45.6% since the first of the year. Vipshop Holdings operates as an online discount retailer for various brands in the People’s Republic of China. For more information, get Portfolio Grader’s complete analysis of VIPS stock.
Since the first of the year, shares of Sucampo Pharmaceuticals, Inc. Class A (SCMP) have soared 46.3%. Sucampo Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. For more information, get Portfolio Grader’s complete analysis of SCMP stock.
Since the first of the year, the price of Grupo Financiero Galicia SA Sponsored ADR Class B (GGAL) has swelled 52.6%. Grupo Financiero Galicia is a financial services holding company. The stock has a trailing PE Ratio of 7.60. For more information, get Portfolio Grader’s complete analysis of GGAL stock.
Since January 1, Ingles Markets, Incorporated Class A (IMKTA) has climbed 53.5%. Ingles Markets operates a supermarket chain in the southeastern United States. For more information, get Portfolio Grader’s complete analysis of IMKTA stock.
Shares of Insperity, Inc. (NSP) have risen 55.1% since January 1. Insperity provides personnel management that encompasses a range of services, including benefits and payroll administration, health and workers’ compensation insurance programs and personnel records management. For more information, get Portfolio Grader’s complete analysis of NSP stock.
Since January 1, Impax Laboratories, Inc. (IPXL) has shot up 62%. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock.
Shares of Ebix, Inc. (EBIX) have leaped 74.9% since January 1. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.
The price of ABIOMED, Inc. (ABMD) has seen an 89.1% boost since the first of the year. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.
Since January 1, the price of Chimera Investment Corporation (CIM) has grown 367.6%. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock’s trailing PE Ratio is 5.60. For more information, get Portfolio Grader’s complete analysis of CIM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
